ReviewTrends in cardiovascular medicine2021
Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021.
Review in Trends in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 33 citations in OpenAlex.
- Impact of COVID-19 on door-to-wire time in ST-segment elevation myocardial infarction treatment: the role of digital communication.BMC cardiovascular disorders · 2025Article
- Article
- Clinical Updates in Coronary Artery Disease: A Comprehensive Review.Journal of clinical medicine · 2024Review
- Patients With ST-Segment Elevation Myocardial Infarction and Cerebrovascular Accidents: Impact of COVID-19 Vaccination on Mortality.Cardiology research · 2024Article
- Retrospective Post-Hospitalisation COVID-19 Mortality Risk Assessment of Patients in South Africa.European journal of investigation in health, psychology and education · 2023Article
- The effect of COVID-19 on the in-hospital outcomes of percutaneous coronary intervention in patients with acute coronary syndrome: A large scale meta-analysis.American journal of medicine open · 2023Article
- Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care.Heart failure clinics · 2023Review
- Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry.Journal of clinical medicine · 2023Article
- Comparison of STEMI Door-To-Device Time During the COVID-19 Crisis in a New Jersey Inner City Community Hospital.Journal of community hospital internal medicine perspectives · 2023Article
- Effect of Ticagrelor Compared to Clopidogrel on Short-term Outcomes of COVID-19 Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention; a Randomized Clinical Trial.Archives of academic emergency medicine · 2023Article
- Changes to the Major Trauma Pre-Hospital Emergency Medical System Network before and during the 2019 COVID-19 Pandemic.Journal of clinical medicine · 2022Article
- Long-term cardiac surveillance and outcomes of COVID-19 patients.Trends in cardiovascular medicine · 2022Review
- Cardiopulmonary resuscitation missed by bystanders: Collateral damage of coronavirus disease 2019.Acta anaesthesiologica Scandinavica · 2022Article
- The Impact of COVID-19 on Lombardy Region ST-Elevation Myocardial Infarction Emergency Medical System Network-A Three-Year Study.Journal of clinical medicine · 2022Article
- Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care.Cardiology clinics · 2022Review
- ST Segment Elevation Myocardial Infarction in the COVID-19 Era: Appraisal of the Evidence.Clinical medicine & research · 2022Article
- Article
- Treatment Delay and Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction during the COVID-19 Pandemic.Journal of clinical medicine · 2021Article
- Editorial commentary: The need for a streamlined approach to STEMI management during the COVID-19 pandemic.Trends in cardiovascular medicine · 2021Article
- Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI.Evidence-based complementary and alternative medicine : eCAM · 2021Article
Corrections and comments
- Commented on by
Authors and funding
11 authors at 5 institutions in 1 country.
Funding
Abstract
As the prevalence of asymptomatic COVID-19 continues to increase, there is an increasing possibility that patients with COVID-19 may presen with ST-segment elevation myocardial infarction (STEMI). With social distancing and restricted access to preventive healthcare and emergency services, the management of acute cardiac emergencies such as myocardial infarction has suffered collateral damage. Thus far, global trends suggest a decrease in STEMI activations with possible worse outcomes due to delayed presentation and management. In this review, we discuss the challenges to STEMI management in the COVID-19 era and provide potential solutions for adherence to evidence-based therapies as the pandemic progresses into the year 2021.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.